Sense Neuro Diagnostics is getting ready to participate in the Arizona Commerce Authority Venture Ready Accelerator, an initiative that helps startups refine business plans, improve go-to-market execution strategies, and increase investor readiness.
Cincinnati-based Sense Neuro Diagnostics is pursuing new international investment opportunities after coming in second place in the Unicorn CUP Finals startup competition. The pitch event is affiliated with Unicorn Events, the world’s largest startup pitch competition that focuses on discovering extraordinary startups that have the potential to achieve a valuation of $1 billion or more.
Sense Diagnostics was recently recognized as one of seven winners of the 2022 Medical Innovation Challenge at the Defense TechConnect (DTC) Innovation Summit & Expo, the nation’s largest annual gathering of non-traditional, dual-use emerging technologies aligned with government priority requirements.
Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, has been selected to participate in the Mayo Clinic and Arizona State University MedTech Accelerator.
Sense receives clearance to expand ongoing clinical trial to evaluate non-invasive brain scanner to sites in India and Canada
Clinical trial underway at five US hospital sites to evaluate Sense’s novel, non-invasive brain scanner to monitor intracranial hemorrhage in acute hospital setting.
LOK Corporation and Sense Neuro Diagnostics Announce Commercial Partnership Focused on International Market
LOK Corporation, and Sense Neuro Diagnostics, today announced a commercial partnership to bring innovative brain scanners being developed by Sense to the international market pending regulatory approval.